Seagen; Adcetris; Opdivo; Ipsen; Alladapt Immunotherapeutics; Biogen; Eisai; Bylvay; ADP101; epinephrine; Leqembi
Today in FirstWord Pharma 's Industry News newsletter, we cover:
?? Seagen says Adcetris, Opdivo regimen leads to 98% response rate in classical Hodgkin lymphoma
? US clears Bylvay for severe itch due to Alagille syndrome
?? Alladapt looks to advance food allergy drug to Phase III
?? Alzheimer's experts hint at tough sell for Eisai, Biogen's lecanemab in EU
Stay ahead of the curve with access to all the important news and insights in the #Pharma industry with FirstWord Pharma's Industry News newsletter!?Sign up to receive our newsletter and get an in-depth view of today's top stories.
?? https://firstwordpharma.com/register